OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response
Christopher J.M. Williams, Allyson Peddle, Pashtoon Murtaza Kasi, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 12, pp. 839-851
Closed Access | Times Cited: 7
Christopher J.M. Williams, Allyson Peddle, Pashtoon Murtaza Kasi, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 12, pp. 839-851
Closed Access | Times Cited: 7
Showing 7 citing articles:
The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer
Jiacheng He, Xiaolei Chai, Qiansen Zhang, et al.
Nature Immunology (2025)
Closed Access | Times Cited: 1
Jiacheng He, Xiaolei Chai, Qiansen Zhang, et al.
Nature Immunology (2025)
Closed Access | Times Cited: 1
LCAT in Cancer Biology: Embracing Epigenetic Regulation, Immune Interactions, and Therapeutic Implications
Manzhi Gao, Wentian Zhang, Xinxin Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1453-1453
Open Access
Manzhi Gao, Wentian Zhang, Xinxin Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1453-1453
Open Access
High baseline levels of PD-L1 reduce the heterogeneity of immune checkpoint signature and sensitize anti-PD1 therapy in lung and colorectal cancers
Peng Fan, Ziwei Qi, Zhenhua Liu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Peng Fan, Ziwei Qi, Zhenhua Liu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Programmed Cell Death Ligand as a Biomarker for Response to Immunotherapy: Contribution of Mass Spectrometry-Based Analysis
Marco Agostini, Pietro Traldi, Mahmoud Hamdan
Cancers (2025) Vol. 17, Iss. 6, pp. 1001-1001
Open Access
Marco Agostini, Pietro Traldi, Mahmoud Hamdan
Cancers (2025) Vol. 17, Iss. 6, pp. 1001-1001
Open Access
Dynamics of tertiary lymphoid structures and immune cross talk in early versus advanced colorectal cancer: potential implications for immunotherapy
Zixu Chen, Bang Hu, Keyu Cai, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 6
Open Access
Zixu Chen, Bang Hu, Keyu Cai, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 6
Open Access
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance
Annachiara Esposito, Antonio De Agostini, Giuseppe Quero, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 12
Open Access | Times Cited: 2
Annachiara Esposito, Antonio De Agostini, Giuseppe Quero, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 12
Open Access | Times Cited: 2
Dysregulation of systemic immunity in colorectal cancer and its clinical applications as biomarkers and therapeutics
LI Chang-qin, Jian Li
Critical Reviews in Oncology/Hematology (2024) Vol. 204, pp. 104543-104543
Closed Access | Times Cited: 1
LI Chang-qin, Jian Li
Critical Reviews in Oncology/Hematology (2024) Vol. 204, pp. 104543-104543
Closed Access | Times Cited: 1
Traditional Chinese medicine and its components effectively reduce resistance mediated by immune checkpoint inhibitors
Mingxin Guo, Wentong Fang, Zhiqiang Hu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Mingxin Guo, Wentong Fang, Zhiqiang Hu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
